Baller Alert
  • Home
    • News
    • Entertainment
    • The Baller Alert Show
    • Baller Alert Lists
    • Baller Alert Exclusives
    • Let Me Liv
    • Ballerific Music
    • That’s Baller
    • Fashion
    • Metaverse
    • Tech
    • Lifestyle
    • Sports
    • Op-Ed
    • Travel
    • Health
  • EVENTS
  • Videos
  • Shop
  • About
  • Political News
  • en español
No Result
View All Result
  • Home
    • News
    • Entertainment
    • The Baller Alert Show
    • Baller Alert Lists
    • Baller Alert Exclusives
    • Let Me Liv
    • Ballerific Music
    • That’s Baller
    • Fashion
    • Metaverse
    • Tech
    • Lifestyle
    • Sports
    • Op-Ed
    • Travel
    • Health
  • EVENTS
  • Videos
  • Shop
  • About
  • Political News
  • en español
No Result
View All Result
Baller Alert
No Result
View All Result

Homegrown COVID-19 Vaccine Approved in China For Widespread Use

by Iesha
December 31, 2020
Reading Time: 2 mins read
0
Coronavirus

istock

Share on FacebookShare on Twitter

China’s first COVID-19 vaccine manufactured by state-owned Sinopharm has earned market approval from China’s medical products agency. The conglomerate claims its vaccine has an efficacy rate of 79%, surpassing the generally recognized 50% efficacy standard.

The approval is conditional and requires that Sinopharm continue to collect vaccine data and its long-term consequences. But the introduction of another mass-produced vaccine could provide relief for countries that have been unable to procure doses of the Pfizer–BioNTech and Moderna vaccines. Just one day after the U.K., China’s approval arrived, a vaccine made by AstraZeneca and Oxford University was approved.

There are two injections needed for the Chinese vaccine. It was founded by a subsidiary of Sinopharm, the China National Biotec Group, or CNBG. The drugmaker says it has been conducting clinical studies in China and other countries, such as the United Arab Emirates, Bahrain, Egypt, Jordan, Peru, Argentina, and Morocco.

“During the summer, Beijing gave a green light for emergency use of the Sinopharm vaccine and several others,” NPR’s John Ruwitch reports for our Newscast unit. “State media say that millions of doses have already been administered, including to front-line medical staff and people going abroad for work. Emergency use is set to expand.”

Earlier this month, both Bahrain and the UAE — where large-scale trials of the Sinopharm vaccine took place — approved the vaccine.

CNBG chairman Yang Xiaoming told Chinese state-run media that China’s new approval for widespread use moves the country closer to its goals of vaccinating millions of more people in the coming months. China would need to vaccinate at least 700 million people to defend itself from COVID-19,

In March, Yang said that he and hundreds of other CNBG workers were inoculated with a version of the company’s vaccine, declaring COVID-19 a global pandemic the same month.

In addition to the effectiveness rate, the potential of vaccines to protect public health is related to another figure: vaccine coverage — the number of people who get the shot and develop antibodies to the virus.

The World Health Organization says, “The percentage of people who need to have antibodies to achieve herd immunity against a particular disease varies with each disease.”  It notes that for measles, around 95% of a population must be vaccinated to achieve herd immunity, while for polio, the threshold is much lower: about 80%.

In addition to these discrepancies, a vaccine’s efficacy rate directly impacts the amount of coverage a country would provide to avoid an infection or decrease it. Researchers have been studying how high an efficacy rate must be to protect the public without any other interventions.

One study recently concluded that a vaccine “has to have an efficacy of at least 70% to prevent an epidemic and of at least 80% to largely extinguish an epidemic without any other measures (e.g., social distancing).”

Coronavirus
istock

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on X (Opens in new window) X
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on Pinterest (Opens in new window) Pinterest

Like this:

Like Loading...

Discover more from Baller Alert

Subscribe to get the latest posts sent to your email.

Tags: ChinaCOVID-19NewsVaccine

Related Posts

50 Cent Reacts to Rumors Daphne Joy Testified in Diddy Trial as Jane Doe
News

50 Cent Reacts After Rumors Swirl That His Ex Testified as Jane Doe in Diddy’s Trial

June 6, 2025

50 Cent is stirring the pot again—but this time, it’s personal. The rap mogul and media executive had social media...

Ex-WWE Exec Linda McMahon Confirmed as Education Secretary Amid Plans to Dismantle Department
News

Education Secretary Clueless About Tulsa Race Massacre in ‘Illegal DEI’ Debate [Video]

June 6, 2025

Education Secretary Linda McMahon faced intense scrutiny during a recent House Education and Workforce Committee hearing when she admitted to...

Keke Palmer, SZA Returning for One of Them Days Sequel
News

Apparently, Rent Still Ain’t Paid—One of Them Days Is Getting a Sequel

June 5, 2025

Get ready for another wild ride—TriStar is bringing back One of Them Days, and yes, Keke Palmer and SZA are...

Trump’s New Travel Ban Hits Africa —Blocking Entry from 19 Countries
News

Trump’s New Travel Ban Hits Africa —Blocking Entry from 19 Countries

June 5, 2025

Donald Trump just signed off on a sweeping new travel ban, shutting down entry into the United States for people...

Next Post
Louis Gossett Jr.

Louis Gossett Jr. Checks Out Of Hospital While Critically Ill With COVID-19

Leave a ReplyCancel reply

Baller News

Subscribe To Our Newsletter

* indicates required

Follow Us

Subscribe to Blog

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

© Copyright 2024, Baller Alert Inc. All Rights Reserved

No Result
View All Result
  • Home
    • News
    • Entertainment
    • The Baller Alert Show
    • Baller Alert Lists
    • Baller Alert Exclusives
    • Let Me Liv
    • Ballerific Music
    • That’s Baller
    • Fashion
    • Metaverse
    • Tech
    • Lifestyle
    • Sports
    • Op-Ed
    • Travel
    • Health
  • EVENTS
  • Videos
  • Shop
  • About
  • Political News
  • en español
%d